150989-01-8 Usage
Description
(E)-Tetradec-9-enoyl chloride, with the molecular formula C14H25ClO, is a chemical compound belonging to the class of enoyl chlorides. It features a 14-carbon chain with a double bond between the 9th and 10th carbon atoms and a chlorine atom attached to the terminal carbon. (E)-Tetradec-9-enoyl chloride is recognized for its reactivity and serves as a versatile intermediate in organic synthesis.
Uses
Used in Pharmaceutical Industry:
(E)-Tetradec-9-enoyl chloride is used as a reagent for the synthesis of various bioactive compounds. Its unique chemical structure allows for the creation of a wide range of organic compounds, including fatty acids, esters, and amides, which can be utilized in the development of pharmaceutical products.
Used in Agrochemical Industry:
In the agrochemical sector, (E)-Tetradec-9-enoyl chloride is employed as a key intermediate in the production of compounds with biological activity. These compounds can be used in the development of pesticides, herbicides, and other agrochemical products to enhance crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 150989-01-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,9,8 and 9 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 150989-01:
(8*1)+(7*5)+(6*0)+(5*9)+(4*8)+(3*9)+(2*0)+(1*1)=148
148 % 10 = 8
So 150989-01-8 is a valid CAS Registry Number.
150989-01-8Relevant articles and documents
IMPROVED COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS
-
Paragraph 0271-0272, (2016/08/17)
The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of specific target protein at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.
